Subject selection biases in clinical trials: data from a multicenter schizophrenia treatment study.
about
Effectiveness of second generation antipsychotics: a systematic review of randomized trialsAre racial and ethnic minorities less willing to participate in health research?Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternativesEffectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone.Comparison of clozapine response for inpatients in the research setting versus routine clinical practiceA public health approach to clinical therapeutics in psychiatry: directions for new research.Participation bias among suicidal adults in a randomized controlled trial.Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practiceEffectiveness as an outcome measure for treatment trials in psychiatry.Schizophrenia Outpatient Health Outcomes study: twelve-month findingsGeneralizability analysis for clinical trials: a simulation study.The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment.Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study.Veteran subjects willingness to participate in schizophrenia clinical trials.Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.The "RCT augmentation": a novel simulation method to add patient heterogeneity into phase III trials.The European Schizophrenia Outpatient Health Outcomes Study: baseline findings across country and treatment
P2860
Q21260262-BB061228-0856-464E-8A29-733F9E287341Q24814743-0F0FFA1F-91B1-489C-B8F2-F0206AD04D71Q26863435-6AA7F069-75A1-4FB0-A031-C1D65322345FQ33545458-DEAF9886-1B22-405B-8656-7E2A0CA26066Q33994937-ADE44967-05F6-426C-80F6-7AD1D69BE950Q35236279-83AF069E-752C-44C6-A1B3-892E6BBCFCE7Q36009134-A4163B42-171B-48E7-8D74-DDA2818CA647Q37029622-149C8C5D-104C-40BD-82E4-5C3995F434D8Q37102823-F48FADF0-AF13-4835-85C8-4DF1A682731FQ37300879-19432AD9-81CE-4545-B117-57F544DEABE8Q40363203-02897CBE-BD5F-4109-AE9D-69200F04DA7FQ44311423-7169815B-05D8-469C-9DB0-3F289EDE5CFBQ45257716-C0FD70AB-1F7E-4598-B284-3EF297FF3A67Q45329830-616E1F56-8ED7-4422-8D0F-EA45F423F8AAQ52016145-AEC3E95D-917F-41DF-9648-112E5D4F0247Q55497101-A6BFE140-B52E-471A-887B-E200960C8626Q57709583-4104E0FD-B8D3-41BA-9017-A23487E1D282
P2860
Subject selection biases in clinical trials: data from a multicenter schizophrenia treatment study.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Subject selection biases in cl ...... schizophrenia treatment study.
@ast
Subject selection biases in cl ...... schizophrenia treatment study.
@en
type
label
Subject selection biases in cl ...... schizophrenia treatment study.
@ast
Subject selection biases in cl ...... schizophrenia treatment study.
@en
prefLabel
Subject selection biases in cl ...... schizophrenia treatment study.
@ast
Subject selection biases in cl ...... schizophrenia treatment study.
@en
P2093
P921
P1476
Subject selection biases in cl ...... schizophrenia treatment study.
@en
P2093
P304
P356
10.1097/00004714-199604000-00009
P407
P577
1996-04-01T00:00:00Z